Cell Constraint & Cancer SA

Proof of Concept in 2014: Action of mechanical Cues in vivo on the Growth of a subcutaneously grafted Tumor (Published 21 April 2016, PloS One, R Brossel et al). 

http://dx.doi.org/10.1371/journal.pone.0152885

Next Step: Proof of Efficacy on orthotopic Graft of Human Pancreatic Cancer in Pancreas of Mice

Combination of two medical devices: A generator of gradient of magnetic field and iron nanoparticles.

We are looking for Partners in the academic and industrial world; We are looking for investors.

Cell Constraint & Cancer (CC & C) is a start-up of biotechnology in support of R&D of a new approach in cancer research. The disruptive innovation (Patent PCT/EP 2014 064995), involves the application of mechanical cues (constraint/stress field) in the treatment of cancer. Physical Oncology defined as the study of cancer tissue with the tools of the solid matter physics is trying to subvert our concept of cancerous tumors.

The demonstration of Proof of Efficacy of this process would consider a crossing to humans by the year 2020. Right now we have begun a feasibility study of Proof of Efficacy, biological as well as physical. Proof of Efficacy itself is planed in Q4, 2016.

CC & C is presently “burning cash”, and is a bet on a success realized by a co-development with a company manufacturer of gradient of magnetic field equipment and/or a pharmaceutical company familiar with injectable ferric nanoparticles.

More Remy Brossel's questions See All
Similar questions and discussions